Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
We are seeking stakeholders’ feedback on the regulation of radiopharmaceuticals in Australia. Radiopharmaceuticals are medicines that contain small amounts of radioactive material and are used to support the diagnosis and treatment of serious conditions, including cancer and cardiovascular disease.
While the consultation is open you can make a submission at our TGA consultation hub. We then review the submissions.
After that, the submissions will be available on the same page at the TGA consultation hub.
About this consultation
We are seeking stakeholders’ feedback on how current regulatory settings operate in practice.
Radiopharmaceutical regulation spans Commonwealth therapeutic goods legislation as well as Commonwealth, state and territory radiation safety and licensing frameworks.
For any questions relating to this consultation, email us at radiopharm@health.gov.au.
All recent consultations can be found on our TGA Consultation hub.